Recent Finacing
Recent Raise
Svenska Vaccinfabriken develops therapeutic proteins, DNA vaccines, and immunotherapies against hepatitis B, hepatitis D and coronaviruses, using a Karolinska-derived platform with preclinical efficacy.
Recent Investors
Funding round
Investor